Publications by authors named "R Laufer"

Claim this Profile
N
Neuroinflammation Based Neurodegenerative In Vitro Model of SH-SY5Y Cells-Differential Effects on Oxidative Stress and Insulin Resistance Relevant to Alzheimer's Pathology.
Csenge Böröczky, Alexandra Paszternák, Rudolf Laufer, Katinka Tarnóczi, Noémi Sikur

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem mass spectrometry-based assay for heparan-N-sulphatase in paediatric CSF: A potential pharmacodynamic biomarker for mucopolysaccharidosis type IIIA therapy.
Roberto Speziale, Michaël Hocquemiller, Xin Mei, Danilo Fabbrini, Savina Malancona, Ralph Laufer

Clin Chim Acta· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022.
Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, Amanda J Driscoll, Daniel R Feikin

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregabalin-Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats.
Nariman Essmat, Anna Rita Galambos, Péter P Lakatos, Dávid Árpád Karádi, Amir Mohammadzadeh, Rudolf Laufer

Pharmaceuticals (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence.
Justin R Ortiz, Rachel S Laufer, Steven M Brunwasser, Flanon Coulibaly, Fatoumata Diallo

J Allergy Clin Immunol Glob· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis